Lindborg Stacy has filed 14 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 56187 shares of Imunon, Inc. ($IMNN) on January 02, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Imunon, Inc. | $IMNN | Lindborg Stacy | President and CEO | A | Stock Option (Right to Buy) | 56187 | $0.00 | 56,187.0000 | 3,070,354 | 9999.99% | 1.83% |
| Sept. 6, 2025 | Imunon, Inc. | $IMNN | Lindborg Stacy | President and CEO | M | Restricted Stock | 1667 | $0.00 | 0.0000 | 14,620,732 | 100.00% | 0.01% |
| Sept. 6, 2025 | Imunon, Inc. | $IMNN | Lindborg Stacy | President and CEO | M | Common Stock | 1667 | $0.00 | 3,818.0000 | 14,620,732 | 77.50% | 0.01% |
| Aug. 4, 2025 | Imunon, Inc. | $IMNN | Lindborg Stacy | President and CEO | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 14,620,732 | 9999.99% | 0.03% |
| March 14, 2025 | Imunon, Inc. | $IMNN | Lindborg Stacy | President and CEO | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 14,620,732 | 9999.99% | 0.51% |
| Jan. 1, 2025 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lindborg Stacy | Director | A | Common Stock | 20000 | $0.00 | 48,229.0000 | 5,021,798 | 70.85% | 0.40% |
| Sept. 6, 2024 | Imunon, Inc. | $IMNN | Lindborg Stacy | President and CEO | A | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 6, 2024 | Imunon, Inc. | $IMNN | Lindborg Stacy | President and CEO | A | Stock Option (Right to Buy) | 63602 | $0.00 | 302,768.0000 | 0 | 26.59% | 0.00% |
| Aug. 15, 2024 | Imunon, Inc. | $IMNN | Lindborg Stacy | President and CEO | P | Imunon Common Stock | 25000 | $0.98 | 264,166.0000 | 0 | 10.45% | 0.00% |
| June 12, 2024 | Imunon, Inc. | $IMNN | Lindborg Stacy | President and CEO | A | Stock Option (Right to Buy) | 112500 | $0.00 | 239,166.0000 | 0 | 88.82% | 0.00% |
| May 13, 2024 | Imunon, Inc. | $IMNN | Lindborg Stacy | President and CEO | A | Stock Option (Right to Buy) | 112500 | $0.00 | 126,666.0000 | 0 | 794.16% | 0.00% |
| March 15, 2024 | Imunon, Inc. | $IMNN | Lindborg Stacy | Director | A | Stock Option (Right to Buy) | 4500 | $0.00 | 14,166.0000 | 0 | 46.55% | 0.00% |
| March 11, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lindborg Stacy | Co-Chief Executive Officer | A | Common Stock | 241935 | $0.00 | 423,435.0000 | 2,871,729 | 133.30% | 8.42% |
| March 17, 2023 | Imunon, Inc. | $IMNN | Lindborg Stacy | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 9,666.0000 | 0 | 26.09% | 0.00% |